Swisspreneur Show

EP #518 - Denys Sutter & Girisha Fernando: Bootstrapping vs. Fundraising: Which path actually wins in the early days?

9 snips
Sep 14, 2025
Girisha Fernando, CEO of Lyfegen — health-tech founder optimizing drug rebate management. Denys Sutter, CEO of condenZero — deep-tech physicist commercializing cryogenic microscope hardware. They debate bootstrapping, grants and VC through speed, risk and R&D limits. Short takes on cash-flow vs. runway pressure, when capital helps scale, and pragmatic funding alternatives.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Early Deep-Tech Is Insensitive To Capital

  • Deep-tech early R&D often doesn't speed up with more money because problems are highly non-linear and interdependent.
  • Denys says non-dilutive grants and staged work buy the time needed more efficiently than early VC cash.
ADVICE

De-Risk Fundraising With Early Traction

  • Show early revenue or product-market fit to de-risk fundraising and attract better investors.
  • Girisha recommends bootstrapping briefly to prove commitment before seeking seed investors.
ANECDOTE

Term Sheet Nearly Imposed Personal Liability

  • Girisha recounts getting a VC term sheet that contained extreme gag clauses and personal liability for founders.
  • Her angels stepped in one day before expiry, giving more freedom to test hypotheses.
Get the Snipd Podcast app to discover more snips from this episode
Get the app